Letter to the Editor Archives - Page 4 of 6 - Revista Brasileira de Ginecologia e Obstetrícia

Dear Editor, I would like to thank Dr. Sriwijitalai & Wiwanitkit for the letter to the editor about our article on the care of pregnant women at the time of the zika virus infection. I would also like to thank you for the opportunity to clarify some of the topics they have mentioned. […]

Dear Editor, The publication by Duarte et al on “Zika Virus Infection in Pregnant Women and Microcephaly” is very interesting. Duarte et al mentioned that “If there are no complications (meningoencephalitis or Guillain-Barré syndrome), further examination is unnecessary to assess systemic impairment” and “Anti-inflammatory drugs should be avoided until the diagnosis of dengue is discarded.” […]

Dear Editor, We read with great interest a recent article by Costa et al entitled “Salivary iron (Fe) ion levels, serum markers of anemia and caries activity in pregnant women.” In this prospective cohort, the authors aimed to investigate the association between salivary iron (Fe) and serum markers of anemia and the development of caries. […]

Medeiros e Melo et al report a case of a patient with pre-eclampsia and peripartum cardiomyopathy (PPCM) successfully treated with the dopamine receptor D2 agonist cabergoline. Treatment with the dopamine receptor agonist bromocriptine is currently being evaluated in a multicenter clinical trial (NCT00998556) that is based on the concept of dopamine agonists inhibiting the enzymatic […]

I certainly agree with Dr. Melo and colleagues that newer treatments are necessary for the therapy of peripartum cardiomyopathy (PPCM); and particularly in those areas of the world with higher mortality and morbidity rates. My hope is to encourage Dr. Melo and colleagues, or others, to carry out a carefully controlled study of either cabergoline […]

It is premature to make a recommendation for treatment of peripartum cardiomyopathy (PPCM) with prolactin inhibition (bromocriptine or cabergoline) as in the one-case report of Melo et al. There are now multiple reports of trials for PPCM subjects in the use prolactin inhibition treatment compared with non-use of this modality that show no statistically significant […]

Dear Editor, Rubella is an important concern in obstetrics. It is a viral illness presenting with fever and skin rash. In a previous report on a seroprevalence study among pregnant women by Ferezin et al, “no patient was positive for IgM, and IgG reactivity was 99.6%.” It should be noted that rubella is an extremely […]